Inventor
GAO XURI
US43 patents
⚠️ This page may combine multiple inventors who share the name “GAO XURI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENANTA PHARM INC
39 patentsUS10538532B2Jan 21, 2020
Hepatitis B antiviral agents
ENANTA PHARM INC17 citations94
US10428070B2Oct 1, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC24 citations94
US10189846B2Jan 29, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC25 citations94
US10179792B2Jan 15, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC17 citations94
US10179131B2Jan 15, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC27 citations94
US11596611B2Mar 7, 2023
Hepatitis B antiviral agents
ENANTA PHARM INC5 citations86
US11384090B2Jul 12, 2022
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC14 citations86
US11352363B1Jun 7, 2022
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC13 citations86
US11339170B1May 24, 2022
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC17 citations86
US10729688B2Aug 4, 2020
Hepatitis B antiviral agents
ENANTA PHARM INC11 citations86
US10723733B2Jul 28, 2020
Hepatitis B antiviral agents
ENANTA PHARM INC13 citations86
US10640511B2May 5, 2020
Hepatitis B antiviral agents
ENANTA PHARM INC13 citations86
US10952978B2Mar 23, 2021
Hepatitis B antiviral agents
ENANTA PHARM INC6 citations84
US10934306B2Mar 2, 2021
Hepatitis B antiviral agents
ENANTA PHARM INC5 citations84
US8367053B2Feb 5, 2013
Cyclosporin analogues
ENANTA PHARM INC9 citations84
US8367618B2Feb 5, 2013
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC6 citations84
US11912714B2Feb 27, 2024
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC6 citations75
US12011425B2Jun 18, 2024
Hepatitis B antiviral agents
ENANTA PHARM INC1 citations73
US9156886B2Oct 13, 2015
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC2 citations63
US8349312B2Jan 8, 2013
Proline substituted cyclosporin analogues
ENANTA PHARM INC4 citations63
US12496282B2Dec 16, 2025
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations62
US12054493B2Aug 6, 2024
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations62
US12398147B2Aug 26, 2025
Macrocyclic spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations52
US11976084B2May 7, 2024
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations52
US11760755B2Sep 19, 2023
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations52
US11472808B2Oct 18, 2022
Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
ENANTA PHARM INC0 citations52
US11236111B2Feb 1, 2022
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations52
US10702528B2Jul 7, 2020
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations52
US9603895B2Mar 28, 2017
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC0 citations52
US12540141B2Feb 3, 2026
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations51
US12145942B2Nov 19, 2024
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations51
US10738035B2Aug 11, 2020
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations42
US10442788B2Oct 15, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations42
US10407445B2Sep 10, 2019
Hepatitis C virus inhibitors
ENANTA PHARM INC0 citations42
US10301255B2May 28, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations42
US10280175B2May 7, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations42
US9765087B2Sep 19, 2017
Benzimidazole derivatives
ENANTA PHARM INC0 citations42
US9732110B2Aug 15, 2017
Nucleoside and nucleotide derivatives
ENANTA PHARM INC0 citations42
US9675632B2Jun 13, 2017
Nucleoside and nucleotide derivatives
ENANTA PHARM INC0 citations42